CHDR’s extensive experience with biomarker research and method optimization can be used to identify or develop new methodologies, which can be tailor-made for a drug with an innovative mechanism of action or therapeutic indication. Such services can include development of laboratory analyses, pharmacological of physiological challenges, imaging techniques and PET ligands, and many more.

Central Nervous System

At CHDR, we can study the pharmacology of CNS drugs using functional test batteries such as NeuroCart, PainCart, and driving simulators, as well as imaging techniques such as resting-state fMRI and PET. Using these tools, CHDR's researchers investigate how the target systems function both in healthy subjects and in patients.

Internal Medicine

Research at CHDR covers a wide range of fields, including Internal Medicine, covering the cardiovascular system, haemostasis, immunology, and dermatology, among others. We are at the forefront of developing novel biomarkers and methods for measuring drug-related effects in all of these research areas.

Imaging Techniques

CHDR has broad experience with a range of imaging techniques, such as resting-state fMRI and PET. We are at the forefront of developing new imaging techniques, or improving existing techniques.

Translational Biomarkers

CHDR highly values the use of biomarkers to predict clinical success. We are constantly busy discovering new biomarkers by combining knowledge, subject marterials and data analysis.